Cardiac Science (NASDAQ:DFIB)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Cardiac Science Charts. Click Here for more Cardiac Science Charts.](/p.php?pid=staticchart&s=N%5EDFIB&p=8&t=15)
City of Miami Selects Cardiac Science as Exclusive Provider of
AEDs for Public Access Defibrillation Program
Miami Joins San Diego and Minneapolis as Third Major U.S. City to Partner With
Cardiac Science
IRVINE, Calif., Nov. 16 /PRNewswire-FirstCall/ -- Cardiac Science, Inc.
(NASDAQ:DFIB), a leading manufacturer of life-saving automatic public-access
defibrillators (AEDs) announced today that it is has been selected as the
exclusive provider of AEDs and comprehensive AED/CPR training and AED program
management services for the city of Miami and the Miami "Team For Life"
Project.
Miami's Team for Life project is a Public Access Defibrillation Program (PAD)
which has been approved by the Miami City Commission and Miami Mayor Manny Diaz
that includes an exclusive public-private partnership agreement between the
city of Miami and Cardiac Science.
The PAD program is being coordinated by the Miami Department of Fire-Rescue
which, in addition to planning the deployment of AEDs, is reaching out to
private citizens through a public awareness campaign on the importance of
defibrillation therapy and the use of AEDs to treat victims of a massive heart
attack, also called sudden cardiac arrest.
The goal of the project is to save lives of local citizens by making AEDs more
accessible in a wide variety of settings throughout the City of Miami. In
addition, the program aims to educate the citizens about the Chain of Survival,
an emergency intervention process that includes early defibrillation and CPR.
Miami's Fire-Rescue Department began the citywide effort last fall with the
purchase of 42 of Cardiac Science's Powerheart(R)-brand AEDs for deployment at
buildings and parks throughout the city.
Among the other areas targeted for AEDs in the future are police facilities and
squad cars, city department offices and public locations where people
congregate. Private businesses throughout Miami will also be given the
opportunity to purchase AEDs and training via the program.
"The goal of our PAD program is making AEDs easily accessible in our community
and at the same time educating our city employees and our citizens on important
AED/CPR skills. We believe this is an important investment that will save
lives in our metropolitan area," said William Bryson, Fire Chief, Miami
Fire-Rescue, which is the key partner in the AED deployment process. "This is a
true public-private partnership and we welcome the help of Cardiac Science in
this comprehensive effort. We chose Cardiac Science based on an extensive
review of all the potential providers in the market and found that Cardiac
Science has both reliable and easy to use AEDs."
Cardiac Science Chairman and CEO Raymond W. Cohen said major cities around the
nation have found that PAD programs enjoin local government and its citizens in
an important community partnership for a worthy cause -- saving lives. Being
selected by the city of Miami as a sole source provider of AEDs and AED/CPR
training services is also another big milestone for Cardiac Science, Cohen
added.
"Miami has joined the growing number of leading cities in the nation --
including Boston, San Diego, Minneapolis, Fort Worth and others -- in embarking
on what has become an essential part of any emergency medical preparation and
response effort -- a Public Access Defibrillation program," said Cardiac
Science Chairman and CEO Raymond W. Cohen. "Being selected by the city of
Miami underscores the value of our AED products and program management
services."
About Sudden Cardiac Arrest (SCA) and AEDs
Currently more than 90 percent of SCA victims die before reaching the hospital
due to the length of time it takes for emergency personnel to arrive on the
scene. In all, about 340,000 Americans die each year from SCA. In fact, a
person's chance of survival is reduced by about 10 percent for every minute
spent waiting for a potentially life-saving defibrillation shock.
Implementation of a successful public access defibrillation program has
achieved survival rates as high as 74 percent if patients received
defibrillation within 3 minutes. The American Heart Association estimates that
as many as 50,000 of these lives can be saved if an automated external
defibrillator is available at the time of the emergency, and someone is nearby
who has been trained to use it. AEDs are becoming more widely available and
are being used in a variety of settings, including airplanes and airports,
government workplaces, office buildings, industrial plants, schools,
universities, casinos, golf courses, sports arenas, homes and health clubs.
About Cardiac Science
Cardiac Science develops, manufactures and markets Powerheart(R)-brand
public-access defibrillators (AEDs) and offers comprehensive AED/CPR training
and AED program management services that facilitate successful deployments. The
Company also makes its AEDs on a private label basis for other leading medical
companies such as Nihon Kohden (Japan) Quinton Cardiology Systems and GE
Healthcare. For more information, please visit http://www.cardiacscience.com/,
email Cardiac Science at or call 1-949-797-3800.
This news release contains "forward-looking statements" within the meaning of
the Private Securities Litigation Reform Act of 1995. In addition, from time
to time the company, or its representatives, have made or may make forward
looking statements orally or in writing. The words "estimate," "potential,"
"intended," "expect," "anticipate," "believe," and similar expressions or words
are intended to identify forward looking statements. Cardiac Science cautions
that these statements are subject to substantial risks and uncertainties and
are qualified by important factors that could cause actual results to differ
materially from those reflected by the forward- looking statements and should
not be relied upon by investors when making an investment decision.
Information on these and other factors is detailed in the Company's Form 10-K
for the year ending December 31, 2003, subsequent quarterly filings, and other
documents filed by the Company with the Securities and Exchange Commission.
For further information, please contact: investors, Matt Clawson of Allen &
Caron Inc, +1-949-474-4300, , for Cardiac Science, Inc.; Michael D. Gioffredi,
Chief Marketing Officer of Cardiac Science, Inc., +1-949-797-3800, .
DATASOURCE: Cardiac Science, Inc.
CONTACT: investors, Matt Clawson of Allen & Caron Inc, +1-949-474-4300,
, for Cardiac Science, Inc.; or Michael D. Gioffredi, Chief
Marketing Officer of Cardiac Science, Inc., +1-949-797-3800,
Web site: http://www.cardiacscience.com/